NASDAQ: NTLA · Health Care / Biotechnology: In Vitro & In Vivo Diagnostic Substances

Intellia Therapeutics Inc.

How Intellia Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$1.9B

Price

$13.23

P/E

-4.6

EPS (TTM)

$-2.86

1-year return

0.8%

Dividend yield

0.0%

52-week range

$8.04–$13.23

Compared with

• Biotechnology: In Vitro & In Vivo Diagnostic Substances industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources